Annual ROE
-14.20%
+53.99%+79.18%
31 December 2023
Summary:
Innate Pharma SA annual return on equity is currently -14.20%, with the most recent change of +53.99% (+79.18%) on 31 December 2023. During the last 3 years, it has risen by +19.37% (+57.70%). IPHA annual ROE is now -186.22% below its all-time high of 16.47%, reached on 31 December 2016.IPHA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-72.79%
-59.11%-432.09%
30 June 2024
Summary:
Innate Pharma SA quarterly return on equity is currently -72.79%, with the most recent change of -59.11% (-432.09%) on 30 June 2024. Over the past year, it has increased by +6.37% (+8.05%). IPHA quarterly ROE is now -175.48% below its all-time high of 96.44%, reached on 01 April 2019.IPHA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPHA ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +79.2% | +8.1% |
| 3 y3 years | +57.7% | -53.2% |
| 5 y5 years | -679.6% | -222.4% |
IPHA ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +79.2% | -432.1% | +8.1% |
| 5 y | 5 years | -679.6% | +79.2% | -188.9% | +8.1% |
| alltime | all time | -186.2% | +79.2% | -175.5% | +8.1% |
Innate Pharma SA ROE History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | -72.79%(+432.1%) |
| Dec 2023 | -14.20%(-79.2%) | -13.68%(-82.7%) |
| June 2023 | - | -79.16%(+34.4%) |
| Dec 2022 | -68.19%(+71.1%) | -58.90%(+197.3%) |
| June 2022 | - | -19.81%(-49.6%) |
| Dec 2021 | -39.86%(+18.7%) | -39.28%(-17.3%) |
| June 2021 | - | -47.51%(-158.0%) |
| Apr 2021 | - | 81.85%(+1.7%) |
| Jan 2021 | - | 80.48%(-338.2%) |
| Dec 2020 | -33.57%(+214.0%) | -33.79%(-150.0%) |
| Oct 2020 | - | 67.52%(+9.9%) |
| July 2020 | - | 61.44%(-385.4%) |
| June 2020 | - | -21.53%(-137.2%) |
| Apr 2020 | - | 57.81%(+8.4%) |
| Jan 2020 | - | 53.33%(-600.3%) |
| Dec 2019 | -10.69%(-536.3%) | -10.66%(-117.9%) |
| Oct 2019 | - | 59.46%(-6.7%) |
| July 2019 | - | 63.70%(+197.1%) |
| June 2019 | - | 21.44%(-77.8%) |
| Apr 2019 | - | 96.44%(+22.8%) |
| Jan 2019 | - | 78.55%(+3769.5%) |
| Dec 2018 | 2.45% | 2.03%(-97.7%) |
| Oct 2018 | - | 88.18%(+84.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| July 2018 | - | 47.89%(-195.0%) |
| June 2018 | - | -50.42%(-16.8%) |
| Dec 2017 | -56.43%(-442.6%) | -60.62%(+477.3%) |
| June 2017 | - | -10.50%(-164.1%) |
| Dec 2016 | 16.47%(-287.6%) | 16.38%(-695.6%) |
| June 2016 | - | -2.75%(-69.5%) |
| Dec 2015 | -8.78%(-75.4%) | -9.01%(-61.4%) |
| June 2015 | - | -23.34%(-20.4%) |
| Dec 2014 | -35.70%(+302.0%) | -29.32%(+48.1%) |
| June 2014 | - | -19.80%(+98.4%) |
| Dec 2013 | -8.88%(-29.4%) | -9.98%(-34.7%) |
| June 2013 | - | -15.28%(+18.6%) |
| Dec 2012 | -12.58%(-48.9%) | -12.88%(-8.3%) |
| June 2012 | - | -14.04%(-43.3%) |
| Dec 2011 | -24.62%(-23.9%) | -24.76%(-34.3%) |
| June 2011 | - | -37.66%(+12.8%) |
| Dec 2010 | -32.34%(-4.7%) | -33.39%(+5.9%) |
| June 2010 | - | -31.53% |
| Dec 2009 | -33.95%(+22.0%) | - |
| Dec 2008 | -27.82%(+67.0%) | - |
| Dec 2007 | -16.66%(+7.6%) | - |
| Dec 2006 | -15.48%(-51.8%) | - |
| Dec 2005 | -32.11% | - |
FAQ
- What is Innate Pharma SA annual return on equity?
- What is the all time high annual ROE for Innate Pharma SA?
- What is Innate Pharma SA annual ROE year-on-year change?
- What is Innate Pharma SA quarterly return on equity?
- What is the all time high quarterly ROE for Innate Pharma SA?
- What is Innate Pharma SA quarterly ROE year-on-year change?
What is Innate Pharma SA annual return on equity?
The current annual ROE of IPHA is -14.20%
What is the all time high annual ROE for Innate Pharma SA?
Innate Pharma SA all-time high annual return on equity is 16.47%
What is Innate Pharma SA annual ROE year-on-year change?
Over the past year, IPHA annual return on equity has changed by +53.99% (+79.18%)
What is Innate Pharma SA quarterly return on equity?
The current quarterly ROE of IPHA is -72.79%
What is the all time high quarterly ROE for Innate Pharma SA?
Innate Pharma SA all-time high quarterly return on equity is 96.44%
What is Innate Pharma SA quarterly ROE year-on-year change?
Over the past year, IPHA quarterly return on equity has changed by +6.37% (+8.05%)